Sucampo Pharmaceuticals, Inc.
| Use attributes for filter ! | |
| Headquarters | Bethesda |
|---|---|
| Maryland | |
| United States | |
| Founded | 1996 |
| Subsidiaries | Vtesse, Inc. |
| R-Tech Ueno, Ltd. | |
| Sucampo AG | |
| Parent organizations | Mallinckrodt |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046041 |
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. was a public, American biopharmaceutical company focused on medical applications of a class of ion channel modulators called prostones. A subsidiary of Mallinckrodt plc closed its acquisition of the company on February 13, 2018.
